Iron protects astrocytes from 6-hydroxydopamine toxicity

Neuropharmacology

Volumn 48, Issue 5, 2005, Pages 720-731

  Raicevic, Nevena ^a   Mladenovic, Aleksandra ^a   Perovic, Milka ^a   Harhaji, Ljubica ^a   Miljkovic, Djordje ^a   Trajkovic, Vladimir ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

6 Hydroxydopamine; Astrocytes; Iron; Parkinson's disease

Indexed keywords

1,10 PHENANTHROLINE; DNA FRAGMENT; FERROUS CHLORIDE; FERROUS SULFATE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IRON; LACTATE DEHYDROGENASE; MAGNESIUM SULFATE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOPAMINE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; AUTOOXIDATION; CELL KILLING; CELL LINE; CELL STRAIN; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 16244389962     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.12.003     Document Type: Article

References (51)

1. 2+ exchanger in C6 glioma cells Journal of Neurochemistry 74 2000 1505 1513
2. R. Andrew, D.G. Watson, S.A. Best, J.M. Midgley, H. Wenlong, and R.K. Petty The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls Neurochemical Research 18 1993 1175 1177
3. M. Aschner, and H.K. Kimelberg The use of astrocytes in culture as model systems for evaluating neurotoxic-induced-injury Neurotoxicology 12 1991 505 517
4. B. Bandy, P.B. Walter, J. Moon, and A.J. Davison Reaction of oxygen with 6-hydroxydopamine catalyzed by Cu, Fe, Mn, and V complexes: identification of a thermodynamic window for effective metal catalysis Archives of Biochemistry and Biophysics 389 2001 22 30
5. M.F. Beal Experimental models of Parkinson's disease Nature Reviews Neuroscience 2 2001 325 334
6. D. Ben-Shachar, G. Eshel, J.P. Finberg, and M.B. Youdim The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons Journal of Neurochemistry 56 1991 1441 1444
7. D. Ben-Shachar, N. Kahana, V. Kampel, A. Warshawsky, and M.B. Youdim Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lesion in rats Neuropharmacology 46 2004 254 263
8. D. Berg, M. Gerlach, M.B. Youdim, K.L. Double, L. Zecca, P. Riederer, and G. Becker Brain iron pathways and their relevance to Parkinson's disease Journal of Neurochemistry 79 2001 225 236
9. D. Blum, S. Torch, M.F. Nissou, A.L. Benabid, and J.M. Verna Extracellular toxicity of 6-hydroxydopamine on PC12 cells Neuroscience Letters 283 2000 193 196
10. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Progress in Neurobiology 65 2001 135 172
11. J.P. Bolanos, S.J. Heales, J.M. Land, and J.B. Clark Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture Journal of Neurochemistry 64 1995 1965 1972
12. L. Chen, Y. Wang, L.K. Kairaitis, Y. Wang, B.H. Zhang, and D.C. Harris Molecular mechanisms by which iron induces nitric oxide synthesis in cultured proximal tubule cells Experimental Nephrology 9 3 2001 198 204 (related articles, links)
13. W.S. Choi, D.S. Eom, B.S. Han, W.K. Kim, B.H. Han, E.J. Choi, T.H. Oh, G.J. Markelonis, J.W. Cho, and Y.J. Oh Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons Journal of Biological Chemistry 279 2004 20451 20460
14. R. von Coelln, S. Kugler, M. Bahr, M. Weller, J. Dichgans, and J.B. Schulz Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals Journal of Neurochemistry 77 2001 263 273
15. G. Cohen, and R.E. Heikkila The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents Journal of Biological Chemistry 249 1974 2447 2452
16. H.C. Curtius, M. Wolfensberger, B. Steinmann, U. Redweik, and J. Siegfried Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus Journal of Chromatography 99 1974 529 540
17. P. Damier, E.C. Hirsch, P. Zhang, Y. Agid, and F. Javoy-Agid Glutathione peroxidase, glial cells and Parkinson's disease Neuroscience 52 1993 1 6
18. Z. Darzynkiewicz, S. Bruno, G. Del Bino, W. Gorczyca, M.A. Hotz, P. Lassota, and F. Traganos Features of apoptotic cells measured by flow cytometry Cytometry 13 1992 795 808
19. K.L. Double, M. Maywald, M. Schmittel, P. Riederer, and M. Gerlach In vitro studies of ferritin iron release and neurotoxicity Journal of Neurochemistry 70 1998 2492 2499
20. F. Feger, H. Ferry-Dumazet, M. Mamani Matsuda, J. Bordenave, M. Dupouy, A.K. Nussler, M. Arock, L. Devevey, J. Nafziger, J.J. Guillosson, J. Reiffers, and M.D. Mossalayi Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide Cancer Research 61 2001 5289 5294
21. D.A. Flick, and G.E. Gifford Comparison of in vitro cell cytotoxic assays for tumor necrosis factor Journal of Immunological Methods 68 1984 167 175
22. L.S. Forno, L.E. DeLanney, I. Irwin, D. Di Monte, and J.W. Langston Astrocytes and Parkinson's disease Progress in Brain Research 94 1992 429 436
23. K.S. Ha, K.M. Kim, Y.G. Kwon, S.K. Bai, W.D. Nam, Y.M. Yoo, P.K. Kim, H.T. Chung, T.R. Billiar, and Y.M. Kim Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation FASEB Journal 17 2003 1036 1047
24. L. Harhaji, O. Vuckovic, D. Miljkovic, S. Stosic-Grujicic, and V. Trajkovic Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production Clinical and Experimental Immunology 137 2004 109 116
25. Y. He, T. Lee, and S.K. Leong 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra Brain Research 858 2000 163 166
26. E.C. Hirsch, S. Hunot, P. Damier, B. Brugg, B.A. Faucheux, P.P. Michel, M. Ruberg, M.P. Muriel, A. Mouatt-Prigent, and Y. Agid Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease Advances in Neurology 80 1999 9 18
27. B.J. Hoffer, A. Hoffman, K. Bowenkamp, P. Huettl, J. Hudson, D. Martin, L.F. Lin, and G.A. Gerhardt Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo Neuroscience Letters 182 1994 107 111
28. S.W. Hoffman, B.A. Rzigalinski, K.A. Willoughby, and E.F. Ellis Astrocytes generate isoprostanes in response to trauma or oxygen radicals Journal of Neurotrauma 17 2000 415 420
29. E. Iwata-Ichikawa, Y. Kondo, I. Miyazaki, M. Asanuma, and N. Ogawa Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis Journal of Neurochemistry 72 1999 2334 2344
30. K. Jellinger, L. Linert, E. Kienzl, E. Herlinger, and M.B. Youdim Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease Journal of Neural Transmission Supplement 46 1995 297 314
31. K. Jellinger, W. Paulus, I. Grundke-Iqbal, P. Riederer, and M.B. Youdim Brain iron and ferritin in Parkinson's and Alzheimer's diseases Journal of Neural Transmission. Parkinson Disease and Dementia Section 2 1990 327 340
32. G. Kress, E.D. Kirk, and I.J. Reynolds The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes Journal of Neuroscience 22 2002 5848 5855
33. S.M. Kulich, and C.T. Chu Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease Journal of Neurochemistry 77 2001 1058 1066
34. Y. Levites, M.B. Youdim, G. Maor, and S. Mandel Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-κB (NF-κB) activation and cell death by tea extracts in neuronal cultures Biochemical Pharmacology 63 2002 21 29
35. W. Linert, E. Herlinger, R.F. Jameson, E. Kienzl, K. Jellinger, and M.B. Youdim Dopamine, 6-hydroxydopamine, iron, and dioxygen - their mutual interactions and possible implication in the development of Parkinson's disease Biochimica et Biophysica Acta 1316 1996 160 168
36. D. Lobner Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? Journal of Neuroscience Methods 96 2000 147 152
37. D.S. Maharaj, J.L. Limson, and S. Daya 6-Hydroxymelatonin converts Fe (III) to Fe (II) and reduces iron-induced lipid peroxidation Life Sciences 72 2003 1367 1375
38. M.J. Marti, J. Saura, R.E. Burke, V. Jackson-Lewis, A. Jimenez, M. Bonastre, and E. Tolosa Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat Brain Research 958 2002 185 191
39. M.P. Mattson, and R.J. Mark Excitotoxicity and excitoprotection in vitro Advances in Neurology 71 1996 1 30
40. P. Matzinger The JAM test. A simple assay for DNA fragmentation and cell death Journal of Immunological Methods 145 1991 185 192
41. K.D. McCarthy, and J. de Vellis Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue Journal of Cellular Biology 85 1980 890 902
42. G. Nie, C. Jin, Y. Cao, S. Shen, and B. Zhao Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells Archives of Biochemistry and Biophysics 397 2002 84 90
43. S.H. Park, W.S. Choi, S.Y. Yoon, Y.S. Ahn, and Y.J. Oh Activation of NF-κB is involved in 6-hydroxydopamine-but not MPP(+)-induced dopaminergic neuronal cell death: its potential role as a survival determinant Biochemical and Biophysical Research Communications 322 2004 727 733
44. F. Reno, E. Falcieri, F. Luchetti, S. Burattini, and S. Papa Discrimination of apoptotic cells in flow cytometry using trypan blue and FDA European Journal of Histochemistry 41 Supplement 2 1997 115 116
45. E. Shimizu, K. Hashimoto, N. Komatsu, and M. Iyo Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells Neuropharmacology 43 2002 434 443
46. R. Soto-Otero, E. Mendez-Alvarez, A. Hermida-Ameijeiras, A.M. Munoz-Patino, and J.L. Labandeira-Garcia Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease Journal of Neurochemistry 74 2000 1605 1612
47. N. Takai, H. Nakanishi, K. Tanabe, T. Nishioku, T. Sugiyama, M. Fujiwara, and K. Yamamoto Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine Journal of Neuroscience Research 54 1998 214 222
48. K.L. Tsai, S.M. Wang, C.C. Chen, T.H. Fong, and M.L. Wu Mechanism of oxidative stress-induced intracellular acidosis in rat cerebellar astrocytes and C6 glioma cells Journal of Physiology 502 1997 161 174
49. H.H. Versteeg, E. Nijhuis, G.R. Van Den Brink, M. Evertzen, G.N. Pynaert, S.J. Van Deventer, P.J. Coffer, and M.P. Peppelenbosch A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein Biochemical Journal 3 2000 717 722
50. S. Xiong, H. She, H. Takeuchi, B. Han, J.F. Engelhardt, C.H. Barton, E. Zandi, C. Giulivi, and H. Tsukamoto Signaling role of intracellular iron in NF-κB activation Journal of Biological Chemistry 278 2003 17646 17654
51. O. Yamanoshita, T. Saito, K. Takahashi, T. Hosokawa, M. Okabe, K. Ito, and M. Kurasaki 2,4,5-Trichlorophenoxyacetic acid inhibits apoptosis in PC12 cells Life Sciences 69 2001 403 408